HTTP 200 OK
Allow: GET, PUT, PATCH, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"resource_uri": "https://fragdenstaat.de/api/v1/message/592321/",
"id": 592321,
"url": "https://fragdenstaat.de/anfrage/korrespondenz-mit-deutschen-behorden-zum-tlw-impfstopp-der-astrazeneca-impfung-am-30032021/#nachricht-592321",
"request": "https://fragdenstaat.de/api/v1/request/217097/",
"sent": true,
"is_response": true,
"is_postal": false,
"is_draft": false,
"kind": "email",
"is_escalation": false,
"content_hidden": false,
"sender_public_body": "https://fragdenstaat.de/api/v1/publicbody/16035/",
"recipient_public_body": null,
"status": "awaiting_response",
"timestamp": "2021-04-29T17:11:08+02:00",
"registered_mail_date": null,
"redacted": false,
"not_publishable": false,
"attachments": [],
"subject": "ASK-81593 Korrespondenz mit deutschen Behörden zum tlw. Impfstopp der AstraZeneca-Impfung am 30.03.2021 [#217097]",
"content": "Dear Sir/Madam,\nI write with an update on the above request. Unfortunately, due to the current high volume of requests resulting in an excessive workload, we are not in a position to issue a decision concerning the release of the above request within the initial timeline of 15 working days provided for in Article 7(1) of Regulation (EC) No 1049/2001 (\"Regulation\"). The Agency is required, in these exceptional circumstances, to extend this deadline by another 15 working days in accordance with Article 7(3) of the Regulation. This decision to extend is in line with the principle set out in our Policy on access to documents (available at https://www.ema.europa.eu/en/documents/other/policy/0043-european-medicines-agency-policy-access-documents_en.pdf ) which states that the Agency will apply the principle of proportionality in order to avoid the core business tasks of the Agency and its performance being jeopardised by the administrative workload related to activities within Regulation 1049/2001. Under the above stated Regulation, you will receive a reply within 30 working days (initial period of 15 working days + 15 working days extension).\nThe deadline has therefore been extended to 25 May 2021\nPlease accept our apologies for any inconvenience that this may cause.\n\n\nDocuments Access and Publication Service\nStakeholders and Communication Division\n\nEuropean Medicines Agency\nDomenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands\nTelephone +31 (0)88 781 6000\nwww.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>\n\n\nFollow us: [Twitter-icon] <https://twitter.com/EMA_News> [RSS-icon] <http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/landing/rss_feed.jsp&mid=WC0b01ac058007c0e8> [Youtube-icon] <https://www.youtube.com/user/emainfo>\n\n[EMA_logo]<http://www.ema.europa.eu/ema/>\n\nThis message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.\n\n\nClassified as confidential by the European Medicines Agency\n\n________________________________________________________________________\nThis e-mail has been scanned for all known viruses by European Medicines Agency.\n________________________________________________________________________",
"redacted_subject": [
[
false,
"ASK-81593 Korrespondenz mit deutschen Behörden zum tlw. Impfstopp der AstraZeneca-Impfung am 30.03.2021 [#217097]"
]
],
"redacted_content": [
[
false,
"Dear Sir/Madam,\nI write with an update on the above request. Unfortunately, due to the current high volume of requests resulting in an excessive workload, we are not in a position to issue a decision concerning the release of the above request within the initial timeline of 15 working days provided for in Article 7(1) of Regulation (EC) No 1049/2001 (\"Regulation\"). The Agency is required, in these exceptional circumstances, to extend this deadline by another 15 working days in accordance with Article 7(3) of the Regulation. This decision to extend is in line with the principle set out in our Policy on access to documents (available at https://www.ema.europa.eu/en/documents/other/policy/0043-european-medicines-agency-policy-access-documents_en.pdf ) which states that the Agency will apply the principle of proportionality in order to avoid the core business tasks of the Agency and its performance being jeopardised by the administrative workload related to activities within Regulation 1049/2001. Under the above stated Regulation, you will receive a reply within 30 working days (initial period of 15 working days + 15 working days extension).\nThe deadline has therefore been extended to 25 May 2021\nPlease accept our apologies for any inconvenience that this may cause.\n\n\nDocuments Access and Publication Service\nStakeholders and Communication Division\n\nEuropean Medicines Agency\nDomenico Scarlattilaan 6 | 1083 HS Amsterdam | The Netherlands\nTelephone +31 (0)88 781 6000\nwww.ema.europa.eu<https://www.ema.europa.eu/en> | For directions, see How to find us<https://www.ema.europa.eu/en/about-us/contact/how-find-us>\n\n\nFollow us: [Twitter-icon] <https://twitter.com/EMA_News> [RSS-icon] <http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/landing/rss_feed.jsp&mid=WC0b01ac058007c0e8> [Youtube-icon] <https://www.youtube.com/user/emainfo>\n\n[EMA_logo]<http://www.ema.europa.eu/ema/>\n\nThis message and any attachment contain information which may be confidential or otherwise protected from disclosure. It is intended for the addressee(s) only and should not be relied upon as legal advice unless it is otherwise stated. If you are not the intended recipient(s) (or authorised by an addressee who received this message), access to this e-mail, or any disclosure or copying of its contents, or any action taken (or not taken) in reliance on it is unauthorised and may be unlawful. If you have received this e-mail in error, please inform the sender immediately.\n\n\nClassified as confidential by the European Medicines Agency\n\n________________________________________________________________________\nThis e-mail has been scanned for all known viruses by European Medicines Agency.\n________________________________________________________________________"
]
],
"sender": "Europäische Arzneimittel-Agentur",
"status_name": "Warte auf Antwort",
"last_modified_at": "2024-01-03T16:02:23.118447+01:00"
}